Allergan, Inc. (AGN) · page 23 of 110
The chart uses a bridge-like structure to reclassify 85% of revenue as 'durable' by excluding the 15% 'Patent Cliff Rx' portion.
Activist deck · before_after · present_solution · balanced density
Slide locked Sign in to view
Slide schematic 4/6
callout 0/1 chart 1/1 metric 0/1 source-note 1/1 title 2/2
2 without position callout 1 · metric 1
calloutmetric · primary
Components 6
callout waterfall-bridge primary source-note action-title headline
Tools 2
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1